Anika Therapeutics, Inc. (ANIK)
19.10
-0.26
(-1.34%)
USD |
NASDAQ |
Oct 02, 16:00
19.12
+0.02
(+0.10%)
After-Hours: 20:00
Anika Therapeutics Total Liabilities (Quarterly) : 46.19M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.19M |
| March 31, 2026 | 45.49M |
| December 31, 2025 | 58.97M |
| September 30, 2025 | 42.63M |
| June 30, 2025 | 40.01M |
| March 31, 2025 | 42.21M |
| December 31, 2024 | 61.64M |
| September 30, 2024 | 51.54M |
| June 30, 2024 | 52.32M |
| March 31, 2024 | 55.21M |
| December 31, 2023 | 73.19M |
| September 30, 2023 | 57.67M |
| June 30, 2023 | 54.87M |
| March 31, 2023 | 61.49M |
| December 31, 2022 | 63.56M |
| September 30, 2022 | 62.81M |
| June 30, 2022 | 67.97M |
| March 31, 2022 | 56.45M |
| December 31, 2021 | 78.22M |
| September 30, 2021 | 62.87M |
| June 30, 2021 | 76.33M |
| March 31, 2021 | 85.60M |
| December 31, 2020 | 108.89M |
| September 30, 2020 | 131.89M |
| June 30, 2020 | 152.08M |
| Date | Value |
|---|---|
| March 31, 2020 | 105.22M |
| December 31, 2019 | 53.86M |
| September 30, 2019 | 37.90M |
| June 30, 2019 | 36.42M |
| March 31, 2019 | 37.59M |
| December 31, 2018 | 22.59M |
| September 30, 2018 | 14.00M |
| June 30, 2018 | 18.81M |
| March 31, 2018 | 20.57M |
| December 31, 2017 | 23.90M |
| September 30, 2017 | 19.84M |
| June 30, 2017 | 20.87M |
| March 31, 2017 | 17.34M |
| December 31, 2016 | 17.47M |
| September 30, 2016 | 16.52M |
| June 30, 2016 | 18.32M |
| March 31, 2016 | 19.09M |
| December 31, 2015 | 24.90M |
| September 30, 2015 | 23.10M |
| June 30, 2015 | 17.44M |
| March 31, 2015 | 15.87M |
| December 31, 2014 | 15.90M |
| September 30, 2014 | 15.79M |
| June 30, 2014 | 16.70M |
| March 31, 2014 | 17.49M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Precigen, Inc. | 126.72M |
| Repligen Corp. | 838.15M |
| Amgen, Inc. | 83.95B |
| Biogen, Inc. | 13.24B |
| BioMarin Pharmaceutical, Inc. | 5.402B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 183.47M |
| Shareholders Equity (Quarterly) | 137.28M |
| Debt to Equity Ratio | 0.1839 |
| Current Ratio | 4.479 |
| Net Debt Paydown Yield | 0.02% |